|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
125,280,000 |
Market
Cap: |
5.31(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$3.16 - $47.08 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 20.8 |
Insider 6 Months : 24.2 |
Insider 3/6 Months : 45.4 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Corbus Pharmaceuticals Holdings is focused on the development of immune modulators that will have application in disease states spanning from immuno-oncology to fibrosis. Co.'s pipeline includes anti-integrin monoclonal antibodies that block activation of Transforming growth factor B (TGFB) and small molecules that activate or inhibit the endocannabinoid system. Co.'s pipeline includes: anti-integrin monoclonal antibodies for the treatment of cancer and fibrosis that inhibit the activation of TGFB; cannabinoid receptor type 1 inverse agonists designed to treat obesity and related metabolic diseases; and lenabasum, a synthetic, oral molecule that activates cannabinoid receptor type 2.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
550,000 |
1,582,632 |
1,582,632 |
1,633,932 |
Total Buy Value |
$23,327,560 |
$46,689,501 |
$46,689,501 |
$46,703,200 |
Total People Bought |
1 |
2 |
2 |
5 |
Total Buy Transactions |
2 |
4 |
4 |
9 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Moran Sean F. |
Chief Financial Officer |
|
2015-12-11 |
4 |
B |
$1.56 |
$1,559 |
D/D |
1,000 |
75,250 |
2.66 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2015-12-10 |
4 |
B |
$1.61 |
$1,611 |
D/D |
1,000 |
74,250 |
2.66 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2015-12-09 |
4 |
B |
$1.67 |
$1,670 |
D/D |
1,000 |
73,250 |
2.66 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2015-12-08 |
4 |
B |
$1.68 |
$1,682 |
D/D |
1,000 |
72,250 |
2.66 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2015-12-07 |
4 |
B |
$1.69 |
$1,689 |
D/D |
1,000 |
71,250 |
2.66 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2015-12-04 |
4 |
B |
$1.72 |
$1,720 |
D/D |
1,000 |
70,250 |
2.66 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2015-12-02 |
4 |
B |
$1.79 |
$1,790 |
D/D |
1,000 |
69,250 |
2.66 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2015-11-24 |
4 |
B |
$1.78 |
$2,670 |
D/D |
1,500 |
68,250 |
2.66 |
- |
|
Cohen Yuval |
Chief Executive Officer |
|
2015-11-23 |
4 |
B |
$1.76 |
$941 |
D/D |
535 |
6,835 |
2.73 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2015-11-20 |
4 |
B |
$1.70 |
$2,548 |
D/D |
1,500 |
66,750 |
2.66 |
- |
|
White Barbara |
Chief Medical Officer |
|
2015-11-19 |
4 |
B |
$1.67 |
$6,680 |
D/D |
4,000 |
118,562 |
2.74 |
- |
|
White Barbara |
Chief Medical Officer |
|
2015-11-19 |
4 |
B |
$1.68 |
$1,176 |
D/D |
700 |
114,562 |
2.66 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2015-11-18 |
4 |
B |
$1.71 |
$2,565 |
D/D |
1,500 |
65,250 |
2.66 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2015-11-17 |
4 |
B |
$1.72 |
$2,583 |
D/D |
1,500 |
63,750 |
2.66 |
- |
|
Burstein Sumner |
Former 10% Holder |
|
2015-11-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
375 |
3,594,471 |
|
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2015-11-16 |
4 |
B |
$1.69 |
$3,372 |
D/D |
2,000 |
62,250 |
2.66 |
- |
|
Cohen Yuval |
Chief Executive Officer |
|
2015-11-13 |
4 |
B |
$1.73 |
$1,471 |
D/D |
850 |
6,300 |
2.73 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2015-09-16 |
4 |
B |
$2.12 |
$10,605 |
D/D |
5,000 |
60,250 |
2.74 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2015-09-15 |
4 |
B |
$2.14 |
$10,720 |
D/D |
5,000 |
55,250 |
2.74 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2015-09-14 |
4 |
B |
$1.96 |
$9,820 |
D/D |
5,000 |
50,250 |
2.74 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2015-09-11 |
4 |
B |
$1.85 |
$9,234 |
D/D |
5,000 |
45,250 |
2.74 |
- |
|
White Barbara |
Chief Medical Officer |
|
2015-09-03 |
4 |
B |
$1.84 |
$18,400 |
D/D |
10,000 |
113,862 |
2.74 |
- |
|
White Barbara |
Chief Medical Officer |
|
2015-08-25 |
4 |
B |
$1.87 |
$11,220 |
D/D |
6,000 |
103,862 |
2.74 |
- |
|
Holmer Alan F |
Director |
|
2015-08-25 |
4 |
OE |
$1.00 |
$10,000 |
D/D |
10,000 |
21,000 |
|
- |
|
Cohen Yuval |
Chief Executive Officer |
|
2015-08-24 |
4 |
B |
$1.95 |
$1,070 |
D/D |
550 |
5,450 |
2.73 |
- |
|
176 Records found
|
|
Page 5 of 8 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|